Want to see IN:MEDICO full AI Analyst Report?

Medico Remedies Ltd. (MEDICO) Price & Analysis

0 Followers

MEDICO Stock Chart & Stats

₹50.16

₹4.58(8.10%)

At close: Jan 08 4:00 PM EST

₹50.16

₹4.58(8.10%)

Day’s Range― - ―

52-Week Range₹31.00 - ₹56.99

Previous CloseN/A

Volume2.72M

Average Volume (3M)12.74K

Market Cap

₹4.01B

Enterprise Value₹3.74B

Total Cash (Recent Filing)₹37.51M

Total Debt (Recent Filing)₹192.04M

Price to Earnings (P/E)30.7

Beta0.31

Next Earnings

Aug 07, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)1.59

Shares Outstanding82,984,000

10 Day Avg. Volume20,955

30 Day Avg. Volume12,740

Financial Highlights & Ratios

PEG Ratio0.70

Price to Book (P/B)3.60

Price to Sales (P/S)1.32

P/FCF Ratio-78.06

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue And Profit GrowthConsistent top-line expansion (revenue accelerating to ~20% in FY2026) with net income up materially from FY2021 to FY2026 indicates durable demand and improving operating leverage. This strengthens cash-earning potential and supports reinvestment and scalable margin gains over medium term.

Balance Sheet StrengthEquity compounding and historically improving leverage provide financial flexibility for growth. A stronger equity base cushions shocks, supports credit capacity, and enables funding of R&D or capacity expansion without immediate reliance on costly external capital for the 2–6 month horizon.

Consistent Returns On EquityStable ROE around ~16% over multiple years signals efficient use of shareholder capital and a repeatable earnings model. Persistently solid returns suggest management allocates capital effectively, supporting sustainable profitability and investor confidence over the medium term.

Bears Say

Weak Cash ConversionOperating cash flow volatility and negative free cash flow in FY2026 highlight weak cash conversion despite accounting profits. This raises risks for funding operations, servicing debt, or investing organically without new external financing, and undermines the durability of reported earnings.

Margin VolatilityMeaningful gross-margin swings and uneven operating profit indicate exposure to input cost, pricing pressure, or product mix shifts. Margin instability reduces predictability of cash flows and makes planning capex and margins-sensitive investments riskier over the medium term.

Rising Borrowings In FY2026An uptick in debt in FY2026 after prior leverage improvement increases financial risk, especially given weak cash conversion. Higher borrowings can raise interest costs and constrain strategic flexibility if cash generation does not recover, pressuring liquidity over the coming months.

Medico Remedies Ltd. News

Medico Remedies Announces 31st AGM Details

Medico Remedies Ltd. ( ($IN:MEDICO) ) has provided an update. Medico Remedies Limited has announced the completion of...

1y ago

MEDICO FAQ

What was Medico Remedies Ltd.’s price range in the past 12 months?

Medico Remedies Ltd. lowest stock price was ₹31.00 and its highest was ₹56.99 in the past 12 months.

What is Medico Remedies Ltd.’s market cap?

Medico Remedies Ltd.’s market cap is ₹4.01B.

When is Medico Remedies Ltd.’s upcoming earnings report date?

Medico Remedies Ltd.’s upcoming earnings report date is Aug 07, 2026 which is tomorrow.

How were Medico Remedies Ltd.’s earnings last quarter?

Medico Remedies Ltd. released its earnings results on May 21, 2026. The company reported ₹0.71 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.71.

Is Medico Remedies Ltd. overvalued?

According to Wall Street analysts Medico Remedies Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Medico Remedies Ltd. pay dividends?

Medico Remedies Ltd. does not currently pay dividends.

What is Medico Remedies Ltd.’s EPS estimate?

Medico Remedies Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medico Remedies Ltd. have?

Medico Remedies Ltd. has 82,984,000 shares outstanding.

What happened to Medico Remedies Ltd.’s price movement after its last earnings report?

Medico Remedies Ltd. reported an EPS of ₹0.71 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.041%.

Which hedge fund is a major shareholder of Medico Remedies Ltd.?

Currently, no hedge funds are holding shares in IN:MEDICO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medico Remedies Ltd.

Medico Remedies Ltd. engages in the manufacture, supply, and exportation of pharmaceutical drugs. Its product portfolio includes general formulations, which consists of general tablets, capsules, and dry syrups; and beta lactum formulations, which comprises penicillin and cephalosporin range of formulations in tablets, capsules, and dry syrups. The company was founded on March 18, 1994 and is headquartered in Thane, India.